The human microbiome is no longer a "hidden organ" but a central pillar of modern precision medicine. As we move through 2026, the shift from merely mapping microbial diversity to engineering functional cures has birthed a rapidly expanding field: Live Biotherapeutic Products (LBPs). From the well-known Escherichia coli Nissle 1917 to complex microbial consortia, LBPs are redefining...
Turkish 
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt